Actively Recruiting
Comparing Autologous Matrix-Induced Chondrogenesis and Microfracture Surgery for Hip Cartilage Damage A Pilot Randomized Trial
Led by McMaster University · Updated on 2026-10-07
40
Participants Needed
1
Research Sites
26 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are conducting a pilot randomized controlled trial to compare two surgical techniques for treating focal articular cartilage defects in the hip. The study includes 40 patients aged 18 to 55 years undergoing primary hip arthroscopy, aiming to evaluate hip function, quality of life, pain, cartilage regeneration, health utility, and adverse events over a 2-year period. This study addresses the effects of autologous matrix-induced chondrogenesis AMIC versus the standard microfracture treatment. Participants will receive hip arthroscopy where unstable cartilage is removed and microfracture is performed by creating tiny perforations in the bone. Those in the AMIC group will additionally have a collagen matrix implant placed over the defect to support cartilage repair. Follow-up visits are scheduled at 6 weeks, 6 months, 12 months, 18 months, and 24 months post-surgery to monitor progress. During the study, participants will undergo assessments including hip function and quality of life measured by the International Hip Outcome Tool iHOT-33, hip pain using a visual analogue scale, cartilage repair evaluated by MRI scoring, health utility, and monitoring for adverse events. The total participation time is 2 years, with multiple evaluations to track recovery and treatment impact.
CONDITIONS
Brief Title
AMIC Compared With Microfracture for Focal Articular Cartilage Damage of the Hip
Research Team
N
Nicole Simunovic, MSc
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here